By Greg Jones, Western Bureau ChiefA bill praised for its potential to cut the skyrocketing costs of compound drugs may not be as successful as was hoped, according to preliminary data gathered by the California Workers’ Compensation Institute.Alex Swedlow, research director for CWCI, said that “very, very preliminary results” of an analysis of data from January shows the average cost of compound drugs since Assembly Bill 378 took effect has increased 86%, compared to the 12-month average price in 2011. “It doesn’t appear to be working as planned,” Swedlow s...
Comments